8-K ·Filed Apr 21, 2026
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish
The strong revenue growth and reduced loss, combined with recent capital raising, suggest improving fundamentals. Monitor the final audited results for confirmation and any guidance updates.
Final — all horizons settled through T+60d ⚠ clustered
NRXS ▼ -10.12% at T+60d
LONG call ✗ call lost -10.12% · α vs SPY -14.90% · entry $7.51 → $6.75
T+1d
-0.80%
call -0.80% · α -0.41%
$7.45
settled 6mo ago
T+5d
+1.07%
call +1.07% · α +1.01%
$7.59
settled 6mo ago
T+20d
-3.46%
call -3.46% · α -6.63%
$7.25
settled 5mo ago
T+60d
-10.12%
call -10.12% · α -14.90%
$6.75
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Neuraxis reported preliminary unaudited Q1 2026 revenue of $1.6M, up 78% YoY from $0.9M, with an operating loss of $1.7M and cash of $7.1M. This follows a recent $11.5M ATM offering, suggesting capital was raised ahead of these improving results.
Key Financial Metrics
EPS
−$0.17
est −$0.20 · +15.0%
Revenue
$1.6M
est $1.4M · +14.3% · +77.8% YoY
Rating
beat
Gross Margin
87.5%
Key Facts
- Q1 2026 revenue: $1.6M (vs $0.9M in Q1 2025), representing 78% YoY growth
- Operating loss: $1.7M (improved from $2.1M in Q3 2025)
- Cash balance: $7.1M as of March 31, 2026
- Filed within 0 days of a 424B5 prospectus supplement increasing ATM capacity to $11.5M
Financial Impact
$1.6M revenue, 78% YoY growth, operating loss narrowed to $1.7M
revenueoperating losscash
Risk Factors
- Preliminary estimates are unaudited and subject to change
- Company continues to operate at a loss
- Dilution from recent ATM offering
Market Snapshot
Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-018376 |
| Document: 0001493152-26-018376-index-headers.html | 0001493152-26-018376 |
| Document: 0001493152-26-018376-index.html | 0001493152-26-018376 |
| Document: 0001493152-26-018376.txt | 0001493152-26-018376 |
| 8-K Data (Synthetic) | 0001493152-26-018376 |
14 reports for NRXS
67% Hit rate @ T+20 Went positive at some point 2 of 3 best @ T+20▲ +17.12%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $7.74 | awaiting T+20 | — | $7.47 (−3.49%) |
Aug 19, 2026 9w ago | 8-K | $6.27 $7.61 | ▲ +21.37% | ▲ +21.37% | $7.47 (+19.14%) |
Aug 11, 2026 11w ago | Press Release | $6.35 $5.73 | ▼ −9.76% | ▼ −8.70% | $7.47 (+17.64%) |
Aug 4, 2026 12w ago | EFFECT | $7.01 $5.81 | ▲ +17.12% | ▲ +15.88% | $7.47 (−6.56%) |
Jul 30, 2026 12w ago | S-3/A | $6.28 $6.02 | ▲ +4.14% | ▲ +8.11% | $7.47 (−18.95%) |
Jul 10, 2026 15w ago | 8-K | $7.14 $7.09 | ▼ −0.70% | ▼ −3.13% | $7.47 (+4.62%) |
May 12, 2026 24w ago | Press Release | $8.27 $6.80 | ▼ −17.78% | ▼ −16.05% | $7.47 (−9.67%) |
May 5, 2026 25w ago | Press Release | $8.69 $7.01 | ▼ −19.33% | ▼ −24.29% | $7.47 (−14.04%) |
Apr 28, 2026 25w ago | DEFA14A | $7.44 $7.29 | ▼ −2.02% | ▼ −8.06% | $7.47 (+0.40%) |
Apr 21, 2026 26w ago | 8-K | $7.51 $7.25 | ▼ −3.46% | ▼ −6.63% | $7.47 (−0.53%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 1h 43m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers